Article
Delta-aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans.
Archives of environmental health - 1 Jan 2000
Bergdahl I A, Gerhardsson L, Schütz A, Desnick R J, Wetmur J G, Skerfving S
Abstract excerpt
Delta-aminolevulinic acid dehydratase (ALAD) polymorphism has been reported to modify lead pharmacokinetics (i.e., individuals who express the ALAD2 allele [ALAD2 subjects] have higher blood lead levels than homozygotes for the ALAD1 allele [ALAD1 subjects]). In our study of 89 lead-exposed workers (7 ALAD2 homozygotes or heterozygotes) and 34 unexposed workers (10 ALAD2 heterozygotes), concentrations of urinary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
